GlassScriptPhysician profile
Terrence Hopkins
NPI 1285677765
$1,488.65
in general payments reported to CMS, 2019-2025
16 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $261 · 2021: $188 · 2022: $218 · 2023: $248 · 2024: $249 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $183.95 | 2020-2025 | Ilumya |
| Ucb, INC. | $173.79 | 2021-2024 | Bimzelx |
| Epi Health, LLC | $156.47 | 2020 | |
| Abbvie INC. | $152.81 | 2019-2025 | |
| Incyte Corporation | $136.25 | 2023-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $119.55 | 2021-2024 | |
| Biofrontera INC. | $104.91 | 2020-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Regeneron Healthcare Solutions, INC. | $94.49 | 2022-2025 | Libtayo |
| Janssen Biotech, INC. | $86.13 | 2022-2024 | Tremfya, Simponi Aria, Simponi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.82 | 2022-2023 | Spevigo |
| Dusa Pharmaceuticals, INC. | $73.91 | 2019 | |
| Amgen INC. | $42.56 | 2021-2023 | Otezla |
| Lilly USA, LLC | $33.14 | 2023 | Taltz, Olumiant |
| Ani Pharmaceuticals, INC. | $20.20 | 2025 | Veregen |
| E.R. Squibb & Sons, L.L.C. | $17.41 | 2023 | Sotyktu |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $16.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Hopkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.